Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis
Nicholas L. Smith(University of Washington), Frits R. Rosendaal(Leiden University Medical Center), Mary Cushman(University of Vermont), Jerome I. Rotter(Harbor–UCLA Medical Center), Nicole L. Glazer(University of Washington), Kenneth Rice(University of Washington), Astrid van Hylckama Vlieg(Leiden University Medical Center), Joshua C. Bis(University of Washington), Edwin G. Bovill, Abbas Dehghan(UK Dementia Research Institute), Christopher J. O’Donnell(Harvard University), Weihong Tang(University of Minnesota), David P. Strachan(St George's, University of London), Thomas Lumley(University of Auckland), Bruce M. Psaty(Services Hospital), Barbara McKnight(University of Washington), Susan R. Heckbert(Wake Forest University)
Cited by 107
Related Papers
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k